ICS-formoterol reliever versus ICS and short-acting β(2)-agonist reliever in asthma: a systematic review and meta-analysis

BACKGROUND: The Global Initiative for Asthma recommends as-needed inhaled corticosteroid (ICS)-formoterol as an alternative to maintenance ICS plus short-acting β(2)-agonist (SABA) reliever at step 2 of its stepwise treatment algorithm. Our aim was to assess the efficacy and safety of these two trea...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:ERJ Open Res
Huvudupphovsmän: Hatter, Lee, Bruce, Pepa, Braithwaite, Irene, Holliday, Mark, Fingleton, James, Weatherall, Mark, Beasley, Richard
Materialtyp: Artigo
Språk:Inglês
Publicerad: European Respiratory Society 2021
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7836558/
https://ncbi.nlm.nih.gov/pubmed/33532465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00701-2020
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk